News and Insights
Oncology Market Access – Trends, Challenges, and Strategies for US Pharmaceutical Companies
With the cost of cancer care set to continue to spiral, manufacturers must understand and adapt to the new access and reimbursement landscape in order to ensure the success of their oncology pipelines.
That’s why eyeforpharma partnered with Numerof & Associates to produce an authoritative whitepaper that frames the changing dynamics in the oncology landscape and provides you with the strategy you need to gain access to the US market.
The whitepaper will ensure you:
- Surmount the barriers to oncology market access with an understanding of the key drivers behind market trends
- Attain reimbursement by familiarising yourself with the most innovative payment schemes being used by US oncology payers
- Understand the evolving role of data to raise the potential for premium pricing and market access
Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.
Whether you need a new plan or a second opinion, Numerof has the insight you're looking for.